Dopamine Agonist-Induced Impulse Control Disorders in Patients With Prolactinoma: A Cross-Sectional Multicenter Study.


Dogansen S. C., Cikrikcili U., Oruk G., Kutbay N. O., Tanrikulu S., Hekimsoy Z., ...More

The Journal of clinical endocrinology and metabolism, vol.104, no.7, pp.2527-2534, 2019 (SCI-Expanded) identifier identifier identifier

Abstract

Context: Dopamine agonist (DA)-induced impulse control disorder (ICD) in patients with prolactinomas is not sufficiently known.